Profile: AngioDynamics Inc (ANGO.O)

ANGO.O on Nasdaq

19.14USD
18 Dec 2014
Price Change (% chg)

-- (--)
Prev Close
$19.14
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
297,187
52-wk High
$19.30
52-wk Low
$13.06

Search Stocks

AngioDynamics, Inc., incorporated in 1992, designs manufacture and sell a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company’s segments include vascular segment and Oncology/Surgery. The Vascular segment, which is responsible for products targeting the venous intervention, dialysis access, thrombus management and peripheral disease markets. The Oncology/Surgery segment, which is responsible for radio frequency (RF) and microwave ablation, embolization, NanoKnife and Habib product lines. On May 21, 2012, the Company acquired Navilyst Medical. In October 2012, the Company acquired Vortex Medical Inc. In February 2013, it acquired certain assets of Microsulis Medical Ltd.

Vascular segment

The Vascular Division manages the Company's Fluid Management, Venous, Angiographic, PTA, Drainage, Thrombolytic, Targeted Renal Therapy, Micro Access Kits, Dialysis, PICC and Port product lines. During fiscal year ended May 31, 2012, the Company's product offering includes the NAMIC Fluid Management portfolio. The NAMIC product line includes an offering of manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers and interventional accessories. Its venous products consist of the Company's VenaCure EVLT laser system and Sotradecol. The Company's VenaCure EVLT laser system products are used in endovascular laser procedures to treat superficial venous disease (varicose veins). With the Company's VenaCure EVLT laser system, laser energy is used to stop the reflux by ablating, or collapsing and destroying, the affected vein. In fiscal 2011, the Company expanded its VenaCure EVLT portfolio by launching a new laser with a 1470 nanometer wavelength. Sotradecol is used for the treatment of small, uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves. The benefit-to-risk ratio should be considered in selected patients who are great surgical risks.

Angiographic products and accessories are used during virtually every peripheral vascular interventional procedure. Angiographic products consist of angiographic catheters, but also include entry needles and guidewires specifically designed for peripheral interventions and fluid management products.

The Company's Soft-Vu angiographic catheter technology incorporates a soft, atraumatic tip that is easily visualized under fluoroscopy. The AngiOptic catheter line is distinguished from other catheters because the entire instrument is visible under fluoroscopy. Accu-Vu provides a soft, radiopaque tip with a choice of platinum radiopaque marker patterns along the shaft for enhanced visibility and accuracy. The Mariner catheter is a hydrophilic-coated angiographic catheter. The AQUA Liner guidewire is a technologically advanced guidewire. It is used to provide access to difficult-to-reach locations in interventional procedures requiring a lubricious wire.

Percutaneous transluminal angioplasty (PTA) procedures are used to open blocked blood vessels and dialysis access sites using a catheter that has a balloon at its tip. The Company's PTA dilation balloon catheters include WorkHorse, WorkHorse II and Profiler. Drainage products percutaneously drain abscesses and other fluid pockets. The Company's line of drainage products, The Total Abscession Family of Drainage Catheters, consists of the Company's Total Abscession General, Biliary, and Nephrostomy drainage catheters. Thrombolytic catheters are used to deliver thrombolytic agents, which are drugs that dissolve blood clots in hemodialysis access grafts, arteries, veins and surgical bypass grafts. The Company's thrombolytic catheters include Pulse Spray Infusion Catheters and Uni Fuse thrombolytic catheters, and SpeedLyser. During fiscal 2011, the Company offers a range of dialysis catheters, which include DuraMax, Schon, Evenmore, Vaxcel, Dura-Flow 2 and SCHON XL. Image-guided vascular access (IGVA), involves the use of imaging equipment to guide the placement of catheters that deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system.

The Company's PICC products include Morpheus CT PICC and Morpheus CT PICC Insertion Kit, Morpheus Smart PICC, Xcela PICC with PASV Valve Technology, Xcela Power Injectible PICC, Xcela PICC Hybrid with PASV Valve Technology and Vaxcel PICC with PASV Valve Technology. The Company's port products and accessories include Vortex, SmartPort and LifeGuard. The Company's Vortex port technology line of ports is a clear-flow port technology. The Smart Port power-injectable port with Vortex technology offers the ability for a clinician to access a vein for both the delivery of medications or fluids and for administering power-injected contrast to perform a Computed Tomography (CT) scan. The LifeGuard Safety Infusion Set and The LifeGuard Vision are used to infuse the Company's ports and complement its port and vascular access catheters.

Oncology/Surgery segment

The Company's Oncology/Surgery Division includes the Company's Radiofrequency Ablation (RFA), embolization and NanoKnife product lines. Radiofrequency Ablation (RFA) products use radiofrequency energy to provide a minimally invasive approach to ablating solid cancerous or benign tumors. The RFA system consists of a radiofrequency generator and a family of disposable devices. The Company also markets the Habib 4X resection device under a distribution agreement with EMcision Limited. In addition to the intra-operative (open surgery) device Habib 4X, AngioDynamics markets a minimally-invasive version of the Habib 4X device, a Laparoscopic 4X unit, which is used in minimally invasive laparoscopic surgery (MILS) procedures in surgical specialties, such as Hepato-Biliary, GI, Surgical Oncology, Transplant Surgery and Urology (Partial Nephrectomy Resections).

The NanoKnife Ablation System is for the surgical ablation of soft tissue. The Nanoknife Ablation System consists of two components: a Low Energy Direct Current and needle-like electrode probes. During fiscal 2011, The Company launched the Embarc Microcatheter and Charter Guidewire.

The Company competes with Boston Scientific Corporation, Cook Medical, Cordis Corporation, C.R. Bard, Medical Components, Inc., Medcomp; Arrow International, Smith's Medical, Vascular Solutions; Covidien subsidiaries and Merit Medical.

Company Address

AngioDynamics Inc

14 Plaza Dr
LATHAM   NY   12110-2166
P: +1518.7981215
F: +1302.6555049

Search Stocks